EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Treatment of Autoimmune Hepatitis

Aparna Goel, Paul Kwo

Clinics in Liver Disease · 2024-02 · 28 (1) · 51-61

DOI: 10.1016/j.cld.2023.07.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinics in Liver Disease, 2024-02. Verfasst von Aparna Goel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Stanford University, Palo Alto, CA 94043, USA. Electronic address: goela21@stanford.edu. Hauptthemen laut MEDLINE: Immunosuppressive Agents, Hepatitis, Autoimmune. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The goal of autoimmune hepatitis treatment is to achieve clinical and biochemical remission, which is associated with significantly improved outcomes. Induction treatment with corticosteroids and the subsequent addition of steroid-sparing therapy with gradual tapering of corticosteroids remains the standard of care. Several alternatives to azathioprine and second-line agents, such as mycophenolate mofetil, tacrolimus, cyclosporine, sirolimus, or rituximab, have been evaluated in those with intolerance or inadequate response to standard-of-care therapy. Treatment withdrawal is achievable in less than 20% of patients after 2 years of sustained remission. Liver transplantation should be considered in those with progressive liver disease or those with complications such as hepatocellular carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunosuppressive AgentsHepatitis, AutoimmuneHumansMycophenolic AcidAzathioprineAdrenal Cortex HormonesTreatment Outcome

Stichwörter der Autor:innen

Autoimmune hepatitisBiochemical remissionImmunosuppressionLiver transplantRecurrent autoimmune hepatitisTreatment failure

Substanzen

Immunosuppressive AgentsMycophenolic AcidAzathioprineAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Stanford University, Palo Alto, CA 94043, USA. Electronic address: goela21@stanford.edu.
  • Division of Gastroenterology and Hepatology, Stanford University, Palo Alto, CA 94043, USA.

Zitieren

APA

Goel, A., & Kwo, P. (2024). Treatment of Autoimmune Hepatitis. Clinics in Liver Disease, 28(1), 51-61. https://doi.org/10.1016/j.cld.2023.07.001

Vancouver

Goel A, Kwo P. Treatment of Autoimmune Hepatitis. Clinics in Liver Disease. 2024;28(1):51-61. doi:10.1016/j.cld.2023.07.001

BibTeX
@article{Goel2024,
  author = {Goel, Aparna and Kwo, Paul},
  title = {Treatment of Autoimmune Hepatitis},
  journal = {Clinics in Liver Disease},
  year = {2024},
  volume = {28},
  number = {1},
  pages = {51--61},
  doi = {10.1016/j.cld.2023.07.001}
}
Kostenlos starten →